EVE Energy Strengthens European Operations Through Compliance, Local Manufacturing, and Regional Services
2.7.2026 08:30:00 CEST | Business Wire | Press release
The Smarter E Europe 2026 opened in Munich on June 23 and runs through June 25, gathering global players from the clean energy sector on one of Europe’s most influential trade exhibition platforms. EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, all-scenario storage solutions, and high-performance EV batteries — showcasing its lithium-sodium dual-technology platform, full product portfolio, and localized European operational layout. During the exhibition, European clients showed strong interest in the company’s product performance and placed strong emphasis on sustained adherence to the EU’s evolving regulatory standards. This industry attitude further underscores that regulatory compliance readiness has become a fundamental prerequisite for accessing the European clean energy market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701651416/en/
The BMW iX3 displayed at the EVE Energy booth features the company’s 46-series large cylindrical batteries for premium European electric vehicles
As the European Union advances implementation of the EU Battery Regulation (EU) 2023/1542, EVE Energy continues to strengthen its long-term presence in Europe through regulatory compliance, localized manufacturing, and regional service capabilities. The company has completed key compliance milestones while expanding its manufacturing and service network to support customers across Europe.
Advancing Compliance for the European Market
EVE Energy has established a comprehensive compliance system covering both power and energy storage batteries. In December 2024, the company received the world's first TÜV SÜD Mark certificate for traction batteries issued under the new EU Battery Regulation. In September 2025, EVE Energy officially launched its battery passport, enabling full lifecycle traceability from raw materials to recycling. Its Mr. Big Family Series also passed industrial battery conformity assessments under the regulation.
Today, EVE Energy has built carbon footprint accounting and supply chain traceability systems for its full battery portfolio, enabling fully compliant product deliveries for both power and energy storage product lines.
Expanding Local Manufacturing Capacity
EVE Energy is also advancing localized manufacturing in Europe. Its battery manufacturing base in Debrecen, Hungary, spans 450,000 square meters with a total investment of approximately €1.307 billion. The first phase, with a planned annual capacity of 30 GWh, is scheduled to begin production in 2027.
Located adjacent to the BMW automotive plant, the Facility is designed to support localized supply, shorten lead times , and reduce cross-border logistics carbon emissions.
The Hungary facility will serve as EVE Energy's first European mass production base for its 46-series large cylindrical batteries for premium European electric vehicles. The cells incorporate a full-tab structure and silicon-carbon anode technology, while their steel-shell design withstands 550 MPa of pressure. The technology has been validated on BMW's Neue Klasse iX3, demonstrating a driving range of 1,007.7 kilometers and enabling an additional approximately 400 kilometers of range with a 10-minute fast-charging.
The project is expected to create more than 1,000 local jobs, contributing to industrial development in Debrecen and the surrounding region.
Strengthening Local Operations Across Europe
To further support European customers, EVE Energy continues to expand its localized operating network. In June 2024, the company officially opened its European regional headquarters in Munich, integrating sales, warehousing, and after-sales services. Four Vendor Managed Inventory (VMI) warehouses have also been set up, supported by localized technical and service teams to deliver robust logistics and operational support across Europe.
In 2024, EVE Energy also introduced its CLS (Co-development, License, Service) business model, combining product co-development, technology licensing, and technical services to support localized industrial cooperation with regional partners.
With 25 years of battery technology development, EVE Energy continues to expand its footprint in Europe through compliance, localized manufacturing, and customer support, providing battery solutions for the region's electrification and energy storage markets.
About EVE Energy
Founded in 2001 and listed on the Shenzhen Stock Exchange in 2009, EVE Energy is a global lithium battery company serving the consumer, mobility, and energy storage markets. The company provides battery technologies and solutions for electric vehicles, energy storage systems, and consumer applications, with manufacturing and service operations supporting customers worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260701651416/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From SaaS to OaaS: BearingPoint expands its business model and launches outcome-based marketplace2.7.2026 09:00:00 CEST | Press release
The new BearingPoint Store brings together AI agents, software products, and outcome-based services to help enterprises translate investments into measurable business results, on a trusted, GDPR-compliant foundation. Management and technology consultancy BearingPoint introduces the BearingPoint Store, a new marketplace that enables enterprises to discover, combine, and scale software solutions with a clear focus on business outcomes rather than standalone software. With this launch, the firm expands its product model beyond traditional software toward AI agents and outcome-based services. The Store is a curated destination where enterprises can discover, compare, and adopt solutions designed to deliver measurable business impact. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260702393148/en/ Management and technology consultancy BearingPoint introduces the BearingPoint Store, a new marketplace that enables enterprises to di
Braun Launches the Next Generation of Electric Shaver With Braun NEVO Introducing a New Dawn of Smooth Touch2.7.2026 08:00:00 CEST | Press release
With over 100 years of exceptional German craftsmanship, Braun introduces Braun NEVO, an electric shaver redefining what a close shave and smooth skin mean. Every element has been reimagined: the sleek unibody stainless steel handle, the revolutionary AeroTouch™ Technology and advanced personalized display deliver a perfectly close shave without sacrificing comfort. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701842080/en/ Braun NEVO Shaver Oliver Grabes, Braun Head of Design, said: “At Braun, we set out to reimagine the shaving experience which led to the development of AeroTouch™ Shaving Technology, a cutting system engineered for ultra-low friction on the skin and high efficiency. This makes Braun NEVO our best shaver* setting a new standard for smooth skin.” Introducing the revolutionary world’s first AeroTouch™ Technology, featuring 250 diamond-sharp cutting edges and an exclusive Ultra gliding foil for a smooth g
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member2.7.2026 08:00:00 CEST | Press release
Brenus Pharma, today announced key appointments to its board of directors. The company welcomes Eric DESSERTENNE, as President & Chairman of the board, succeeding co-founder Jacques GARDETTE, who will remain an active board member. Eric brings extensive experience in healthcare innovation and value creation, having notably led BIOCORP through its development and acquisition by Novo Nordisk. Brenus also appoints Camilla SYLVEST, as a second independent director, following the earlier addition of Diala EZZEDDINE a seasoned US-based biotech executive and entrepreneur. Camilla SYLVEST is an experienced pharmaceutical executive and global business leader, having spent nearly three decades at Novo Nordisk A/S, where she most recently served as Executive Vice President for Global Commercial Strategy, Corporate Communication and Sustainability. She currently serves on the Boards of Argenx SE, Getinge AB, and Zealand Pharma A/S, and has previously served on the Board of Danish Crown A/S and as
Access Advance and Alibaba Announce Alibaba's Expanded Participation in the VDP Pool2.7.2026 02:00:00 CEST | Press release
Access Advance LLC and Alibaba Group today announced that Alibaba has joined the Access Advance Video Distribution Patent Pool (VDP Pool) as a Licensee, securing a license to the pool's comprehensive coverage of HEVC, VVC, VP9, and AV1 codec technologies. The announcement marks a milestone in a multi-year collaboration between the two companies that spans the VVC Advance Patent Pool, where Alibaba participates as both a Licensor and Licensee, and the VDP Pool, where Alibaba joined as a Licensor in 2025. Alibaba's subsidiary Youku, one of China's leading streaming platforms, also joined the VDP Pool as a Licensee in 2025. Alibaba operates one of the world's most diverse video ecosystems, spanning a wide range of video-based services across e-commerce, entertainment, and digital media. As video has become central to how consumers shop, communicate, and access entertainment, the breadth of Alibaba's video operations reflects the kind of business model complexity the VDP Pool was designed
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia2.7.2026 01:58:00 CEST | Press release
- First and only approved genetic therapy to treat children as young as 2 years for both severe sickle cell disease and transfusion-dependent beta thalassemia -- Approximately 5,500 additional children in the U.S. are now eligible for this established one-time therapy, expanding upon the prior FDA approval in people 12 years and older -- Regulatory review for label expansion underway in the Kingdom of Saudi Arabia and United Kingdom - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY® (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the first approved genetic therapy indicated for children as young as 2 years for both SCD and TDT. “Just as we redefined what is possible in cystic fibrosis, our ambition is to transform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom